Metabolic syndrome frequency in inflammatory bowel diseases

Background/Aim: Metabolic syndrome (MetS) is a clinical condition characterized by central obesity, elevated triglycerides, low-high density lipoproteins, impaired fasting glucose, and hypertension. There is insufficient data on the prevalence of MetS in patients with inflammatory bowel disease (IBD...

Full description

Bibliographic Details
Main Authors: Elif Yorulmaz, Gupse Adali, Hatice Yorulmaz, Celal Ulasoglu, Guralp Tasan, Ilyas Tuncer
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2011-01-01
Series:The Saudi Journal of Gastroenterology
Subjects:
Online Access:http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2011;volume=17;issue=6;spage=376;epage=382;aulast=Yorulmaz
id doaj-3ecfe69853b04473889d960b6fdda159
record_format Article
spelling doaj-3ecfe69853b04473889d960b6fdda1592020-11-24T21:29:03ZengWolters Kluwer Medknow PublicationsThe Saudi Journal of Gastroenterology1319-37671998-40492011-01-0117637638210.4103/1319-3767.87177Metabolic syndrome frequency in inflammatory bowel diseasesElif YorulmazGupse AdaliHatice YorulmazCelal UlasogluGuralp TasanIlyas TuncerBackground/Aim: Metabolic syndrome (MetS) is a clinical condition characterized by central obesity, elevated triglycerides, low-high density lipoproteins, impaired fasting glucose, and hypertension. There is insufficient data on the prevalence of MetS in patients with inflammatory bowel disease (IBD). This study sought to determine the prevalence of MetS in a Turkish cohort of patients with IBD and the association between insulin resistance (IR) and the MetS parameters, in this population. Patients and Methods: A total of 177 patients over 18 years of age (62 with Crohn′s disease (CD) and 115 with ulcerative colitis (UC)) were enrolled in the study. The presence of at least three criteria of the International Diabetes Federation (IDF) was accepted for the diagnosis of MetS. The Homeostasis Model Assessment (HOMA) was used to determine IR. HOMA values < 1 were considered normal and values > 2.5 indicated a high probability of IR. Results: MetS frequency was higher in patients n=34 (29.5%) with UC than in patients n=11 (17.7%) with CD (P < 0.01). MetS was detected in 12 of the 117 patients (10.3%) with IBD, under 45 years of age, and in 33 of 60 patients (55%) over 45 years of age. HOMA value in n=31 patients (27%) with UC was > 2.5. Body mass index, insulin (P < 0.001), waist circumference, fasting plasma glucose, leukocyte count (P < 0.01), triglycerides, C-reactive protein, and uric acid values (P < 0.05) were significantly higher in UC patients with IR than those without IR. Conclusion: Frequent occurrence of MS with increasing age in IBD, particularly in UC, showed the importance of early diagnosis and treatment of cardiovascular disease risk factors in the long-term follow-up of these diseases.http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2011;volume=17;issue=6;spage=376;epage=382;aulast=YorulmazInflammatory bowel diseaseinsulin resistancemetabolic syndromeobesity
collection DOAJ
language English
format Article
sources DOAJ
author Elif Yorulmaz
Gupse Adali
Hatice Yorulmaz
Celal Ulasoglu
Guralp Tasan
Ilyas Tuncer
spellingShingle Elif Yorulmaz
Gupse Adali
Hatice Yorulmaz
Celal Ulasoglu
Guralp Tasan
Ilyas Tuncer
Metabolic syndrome frequency in inflammatory bowel diseases
The Saudi Journal of Gastroenterology
Inflammatory bowel disease
insulin resistance
metabolic syndrome
obesity
author_facet Elif Yorulmaz
Gupse Adali
Hatice Yorulmaz
Celal Ulasoglu
Guralp Tasan
Ilyas Tuncer
author_sort Elif Yorulmaz
title Metabolic syndrome frequency in inflammatory bowel diseases
title_short Metabolic syndrome frequency in inflammatory bowel diseases
title_full Metabolic syndrome frequency in inflammatory bowel diseases
title_fullStr Metabolic syndrome frequency in inflammatory bowel diseases
title_full_unstemmed Metabolic syndrome frequency in inflammatory bowel diseases
title_sort metabolic syndrome frequency in inflammatory bowel diseases
publisher Wolters Kluwer Medknow Publications
series The Saudi Journal of Gastroenterology
issn 1319-3767
1998-4049
publishDate 2011-01-01
description Background/Aim: Metabolic syndrome (MetS) is a clinical condition characterized by central obesity, elevated triglycerides, low-high density lipoproteins, impaired fasting glucose, and hypertension. There is insufficient data on the prevalence of MetS in patients with inflammatory bowel disease (IBD). This study sought to determine the prevalence of MetS in a Turkish cohort of patients with IBD and the association between insulin resistance (IR) and the MetS parameters, in this population. Patients and Methods: A total of 177 patients over 18 years of age (62 with Crohn′s disease (CD) and 115 with ulcerative colitis (UC)) were enrolled in the study. The presence of at least three criteria of the International Diabetes Federation (IDF) was accepted for the diagnosis of MetS. The Homeostasis Model Assessment (HOMA) was used to determine IR. HOMA values < 1 were considered normal and values > 2.5 indicated a high probability of IR. Results: MetS frequency was higher in patients n=34 (29.5%) with UC than in patients n=11 (17.7%) with CD (P < 0.01). MetS was detected in 12 of the 117 patients (10.3%) with IBD, under 45 years of age, and in 33 of 60 patients (55%) over 45 years of age. HOMA value in n=31 patients (27%) with UC was > 2.5. Body mass index, insulin (P < 0.001), waist circumference, fasting plasma glucose, leukocyte count (P < 0.01), triglycerides, C-reactive protein, and uric acid values (P < 0.05) were significantly higher in UC patients with IR than those without IR. Conclusion: Frequent occurrence of MS with increasing age in IBD, particularly in UC, showed the importance of early diagnosis and treatment of cardiovascular disease risk factors in the long-term follow-up of these diseases.
topic Inflammatory bowel disease
insulin resistance
metabolic syndrome
obesity
url http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2011;volume=17;issue=6;spage=376;epage=382;aulast=Yorulmaz
work_keys_str_mv AT elifyorulmaz metabolicsyndromefrequencyininflammatoryboweldiseases
AT gupseadali metabolicsyndromefrequencyininflammatoryboweldiseases
AT haticeyorulmaz metabolicsyndromefrequencyininflammatoryboweldiseases
AT celalulasoglu metabolicsyndromefrequencyininflammatoryboweldiseases
AT guralptasan metabolicsyndromefrequencyininflammatoryboweldiseases
AT ilyastuncer metabolicsyndromefrequencyininflammatoryboweldiseases
_version_ 1725967812285956096